The Braidwood decision maintains the status quo for many patients, keeping preventive services covered by Medicaid under the ...

Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

The finding that basophil counts may have prognostic significance aligns with a growing body of research into basophils in ...

Both regulatory-approved and pipeline treatments for moderate to severe hidradenitis suppurativa demonstrate comparable ...

In a webinar, panelists discuss Trump's 2025 drug pricing policies, focusing on the Most Favored Nation order, pharmacy ...

Patients with only dry eye had less severe lid margin abnormalities and orifice plugging along with tear film instability ...

This approval comes almost a year after the drug received a complete response letter due to third-party manufacturing issues.

The Supreme Court decision in Medina v Planned Parenthood interprets the Social Security Acts Medicaid provision as not being ...

Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...

Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...

Panelists discuss how integrating subcutaneous (SubQ) therapies into oncology practice involves thorough economic evaluation, ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...